NEW UPDATE#3

3- A letter was delivered 12/04/24 to the U.S. Department of Health and Human Services (HHS), signed by over 30 organizations and individuals, to express serious concerns about the discontinuation of Levemir insulin by Novo Nordisk and to urge HHS to take immediate action to ensure continued access to this critical medication.

3-Read More

UPDATE#2

2- At the Senate HELP Hearing 9/24/24, Senators Hassan, Baldwin, and Collins addressed the Levemir discontinuation.

2-Read More

UPDATE#1

1- The quest to slow the Levemir discontinuation rests largely on an upcoming Senate HELP Committee Hearing on 9/24/24.

1-Read More

APIC

info@alliancetoprotectinsulinchoice.org

Copyright Notice

All Rights Reserved.

All materials appearing on the Alliancetoprotectinsulinchoice.org website (“content”) are protected by copyright under US Copyright laws and are the property of Alliancetoprotectinsulinchoice.org website owners or the party credited as the provider of the content. You may not copy, reproduce, distribute, publish, display, perform, modify, create derivative works, transmit, or in any way exploit any such content, nor may you distribute any part of this content over any network, including a local area network, sell or offer it for sale, or use such content to construct any kind of database. You may not alter or remove any copyright or other notice from copies of the content on the Alliancetoprotectinsulinchoice.org website. Copying or storing any content except as provided above is expressly prohibited without prior written permission of Alliancetoprotectinsulinchoice.org or the copyright holder identified in the individual content’s copyright notice. For permission to use the content on the Alliancetoprotectinsulinchoice.org website, please contact info@alliancetoprotectinsulinchoice.org